|11.11||+0.0600||+0.54%||Vol 2.49M||1Y Perf -37.85%|
|Dec 6th, 2023 16:00 DELAYED|
|- -||0.06 0.54%|
|Target Price||29.17||Analyst Rating||Strong Buy 1.44|
|Potential %||162.56||Finscreener Ranking||— -|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||★★★★ 55.28|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★★★+ 54.17|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||— -|
|Price Range Ratio 52W %||3.68||Earnings Rating||—|
|Market Cap||4.51B||Earnings Date||2nd Nov 2023|
Today's Price Range
|Moving Averages:||Strong Sell|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||-|
|Estimated EPS Next Report||-0.05|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||4.29M|
|Avg. Monthly Volume||3.89M|
|Avg. Quarterly Volume||2.89M|
agilon health inc. (NYSE: AGL) stock closed at 11.11 per share at the end of the most recent trading day (a 0.54% change compared to the prior day closing price) with a volume of 2.49M shares and market capitalization of 4.51B. Is a component of Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 552 people. agilon health inc. CEO is Steven J. Sell.
The one-year performance of agilon health inc. stock is -37.85%, while year-to-date (YTD) performance is -31.16%. AGL stock has a five-year performance of %. Its 52-week range is between 10.41 and 29.44, which gives AGL stock a 52-week price range ratio of 3.68%
agilon health inc. currently has a PE ratio of -62.30, a price-to-book (PB) ratio of 5.84, a price-to-sale (PS) ratio of 3.58, a price to cashflow ratio of -, a PEG ratio of -, a ROA of -6.01%, a ROC of -9.00% and a ROE of -9.65%. The company’s profit margin is -2.49%, its EBITDA margin is -3.60%, and its revenue ttm is $2.02 Billion , which makes it $4.90 revenue per share.
Of the last four earnings reports from agilon health inc., there were 1 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-0.05 for the next earnings report. agilon health inc.’s next earnings report date is -.
The consensus rating of Wall Street analysts for agilon health inc. is Strong Buy (1.44), with a target price of $29.17, which is +162.56% compared to the current price. The earnings rating for agilon health inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
agilon health inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
agilon health inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 51.76, ATR14 : 0.74, CCI20 : -61.95, Chaikin Money Flow : -0.26, MACD : -1.28, Money Flow Index : 31.84, ROC : -6.95, RSI : 34.50, STOCH (14,3) : 33.82, STOCH RSI : 0.88, UO : 40.00, Williams %R : -66.18), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of agilon health inc. in the last 12-months were: Benjamin Kornitzer (Option Excercise at a value of $1 641 478), Benjamin Kornitzer (Sold 189 909 shares of value $4 351 602 ), Benjamin Shaker (Option Excercise at a value of $657 500), Benjamin Shaker (Sold 297 500 shares of value $6 853 600 ), Desai Veeral (Sold 0 shares of value $-570 000 ), Desai Veeral (Sold 190 000 shares of value $5 274 941 ), Gertsch Timothy (Option Excercise at a value of $196 700), John William Wulf (Option Excercise at a value of $720 000), John William Wulf (Sold 160 000 shares of value $3 810 824 ), Schwaneke Jeffrey (Buy at a value of $250 206), Sell Steven (Buy at a value of $497 847), Shaker Benjamin (Option Excercise at a value of $1 262 038), Shaker Benjamin (Sold 422 500 shares of value $9 400 088 ), Veeral Desai (Option Excercise at a value of $556 500), Veeral Desai (Sold 185 500 shares of value $5 157 103 )
Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
General partner of Finscreener is SLOVAKODATA, a.s.
This could take some time, please wait.